$AMBQ

Ambiq Micro (AMBQ) reported Q3 2026 revenue growth of 110% YoY to $38.1M, with gross margins expanding to 48.7%. The company expects similar growth in Q4 and full-year sales of ~$140M. Despite beating earnings expectations, shares fell 4.09% premarket, reflecting investor concerns about profitability and execution risks. Ambiq highlighted its edge AI semiconductor business and product pipeline, including the upcoming Atomiq platform.

Ambiq reported Q3 2026 net sales of $38.1M, up 110% YoY, with GAAP gross profit rising 132% to $17.8M. The company had a GAAP operating loss of $10.0M and net loss of $7.1M. Q4 guidance expects sales of $43.5M-$44.5M. Ambiq cited strong demand across customers and products, with an expanding customer base and new AI software releases.

Ambiq Micro, Inc. (AMBQ) filed an SEC Form 8-K — Results of Operations and Financial Condition. Ambiq Reports Third Quarter 2026 Financial Results Third quarter net sales increased 110% year-over-year on broad demand across customers, product families and form factors Gross profit more than doubled year-over-year, outpacing net sales growth Expect fourth quarter net sales o

UBS kept Ambiq Micro at Neutral, cutting its price target to $50 from $73, a 31.5% reduction. This implies a 15.4% upside from the Nov 2 close of $43.31.

Chen Sean Chihhsiang (President and COO) sold 15,000 shares of Ambiq Micro, Inc. (AMBQ) at an average of $51.50 ($50.13–$54.27, $0.77M total) across 5 trades on 2026-10-14 under a Rule 10b5-1 trading plan.

Ambiq Micro's CFO, Jeffrey Winzeler, sold 5,455 shares for $379,644 in three transactions, citing tax obligations. He now owns 100,844 shares. AMBQ stock fell 14% to $58.56. The company reported 89.7% revenue growth to $33.9M in Q2, narrowing losses to $1.8M. Analysts have mixed views, with price targets ranging from $73 to $85, except BofA's $75 underperform rating.

Jefferies initiated coverage of Ambiq Micro with a buy rating and $90 price target, citing demand for its chips in wearable AI and its expanding AI compute business. The company expects 51% revenue growth annually from 2025 to 2028 and to break even in 2028. Shares have risen 122% year to date.

Stifel highlights Analog Devices, Texas Instruments, and Ambiq as top picks in the Analog and Edge AI semiconductor sector. Ambiq's price target was raised to $85, with expectations of double-digit revenue growth in 2026 and improved gross margins. The firm cites strong competitive positioning and exposure to the growing Edge AI trend.

Analysts made several rating changes: UBS upgraded Invesco (IVZ) to Buy with a $41 target, Raymond James initiated M&T Bank (MTB) as Outperform with a $250 target, Morgan Stanley upgraded Nexa Resources (NEXA) to Overweight, and others. KeyBanc upgraded Corteva (CTVA) to Overweight with a $17 target, Jefferies upgraded Ambiq Micro (AMBQ) to Buy with a $90 target, and Citi upgraded Flutter to Buy with a $91 target.

Jefferies initiated coverage on Ambiq Micro (NYSE: AMBQ) with a buy rating and $90 price target, citing its AI edge computing potential. The company's SPOT architecture offers power advantages for edge devices. Ambiq Micro reported 89.7% revenue growth in Q2, with full-year sales outlook raised to $135 million. Several analysts revised earnings upwards, and multiple firms increased price targets.